Correspondence 0001104659-23-068778 from AYTU BIOPHARMA, INC (AYTU)
AYTU BIOPHARMA, INC
Date: June 7, 2023 · CIK: 0001385818 · Accession: 0001104659-23-068778
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-271556
Letter
Re: Aytu Biopharma, Inc.
June 7, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-1004
Registration Statement on Form S-1, as amended
File No. 333-271556
Ladies and Gentlemen:
As the placement agent of the proposed offering of Aytu Biopharma, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:00 p.m., Eastern Time, on Thursday, June 8, 2023, or as soon thereafter as is practicable.
Pursuant to Rule 460 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that, through June 7, 2023, we distributed to each dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies, as well as “E-red” copies of the Preliminary Prospectus dated June 5, 2023, as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Maxim Group LLC
Show Raw Text
CORRESP
1
filename1.htm
June 7, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-1004
Re:
Aytu Biopharma, Inc.
Registration Statement on Form S-1, as amended
File No. 333-271556
Ladies and Gentlemen:
As the placement agent of
the proposed offering of Aytu Biopharma, Inc. (the “Company”), we hereby
join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:00 p.m.,
Eastern Time, on Thursday, June 8, 2023, or as soon thereafter as is practicable.
Pursuant to Rule 460
of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended,
we wish to advise you that, through June 7, 2023, we distributed to each dealer, who is reasonably anticipated to be invited to participate
in the distribution of the security, as many copies, as well as “E-red” copies of the Preliminary Prospectus dated June 5,
2023, as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advise that
they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Maxim Group LLC
By:
/s/ Clifford A. Teller
Name: Clifford A. Teller
Title: Co-President